Immunocore Holdings plc - ADR (IMCR) Company Profile & Statistics

Immunocore Holdings plc - ADR
IMCR
(Nasdaq - US)
Closed
32.22
+0.10 (+0.31%)
in:usd•As of: Nov 22, 2024 15:59 UTC -5
Open
32.69
High
33.24
Low
32.19

About Immunocore Holdings plc - ADR

CEO

Bahija Jallal

Headquarters

92 park drive, milton park, abingdon

oxfordshire, x0 ox14 4ry, united kingdom

Auditor

KPMG LLP

Employees

497

Share Holders

Website

www.immunocore.com

Industry

biotechnology

Sector

health technology

Company Overview

Immunocore Holdings plc is a late-stage biotechnology company. It engages in development of a novel class of T cell receptor bispecific immunotherapies designed to treat diseases, including cancer, infectious and autoimmune disease. Immunocore Holdings plc is based in Abingdon, the United Kingdom.

Immunocore Holdings plc - ADR Statistics

Valuation Measures

Market Capitalization ²	1.61B
Enterprise Value	1.51B
Enterprise Value/EBITDA (ttm)	-23.64
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	4.31
Price to Sales (ttm)	5.50
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	99.14%
Operating Margin (ttm)	-15.87%
Profit Margin (ttm)	-16.83%
Return on Equity (ttm)	-12.84%
Return on Invested Capital (ttm)	-8.06%
Return on Assets (ttm)	-5.09%

Income Statement

Revenue (ttm)	296.31M
Revenue Per Share (ttm)	5.92
Gross Profit (ttm)	293.71M
EBITDA (ttm)³	-63.99M
Net Income Avi to Common (ttm)	-47.05M
Diluted EPS (ttm)	-0.95

Share Statistics

Beta (5Y Monthly)	0.72
52-Week Change	-29.19%
S&P500 52-Week Change	31.00%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	50.03M
Dividend Yield	0.00%
Float ⁴	45.48M
% Held by Insiders	9.10%
% Held by Institutions	84.50%

Balance Sheet

Total Cash (mrq)	901.28M
Total Cash Per Share (mrq)	18.01
Total Debt (mrq)	438.69M
Total Debt/Equity (mrq)	116.11%
Current Ratio (mrq)	3.78%
Quick Ratio (mrq)	3.76%
Book Value Per Share (mrq)	7.55

Cash Flow

Operating Cash Flow Per Share (ytd)	0.76
Free Cash Flow (ytd)	38.42M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Immunocore Holdings plc - ADR

Trade With A Regulated Broker